Invacare 2015 Annual Report Download - page 37

Download and view the complete annual report

Please find page 37 of the 2015 Invacare annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 140

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140

I-31
Square
Feet
Ownership
Or Expiration
Date of Lease
Renewal
Options Use
European Operations
Oakdale, Pennsylvania . . . . . . . . . . . 5,543 September 2016 One (1 yr.) Warehouse and Offices
Oporto, Portugal . . . . . . . . . . . . . . . . 88,270 November 2016 One (1 yr.) Manufacturing, Warehouse and Offices
Oskarshamn, Sweden . . . . . . . . . . . . 1,076 December 2016 One (1 yr.) Warehouse
Oslo, Norway . . . . . . . . . . . . . . . . . . 24,262 April 2016 One (6 mos.) Manufacturing, Warehouse and Offices
Pencoed, United Kingdom . . . . . . . . 150,000 December 2019 None Manufacturing and Offices
Porta Westfalica, Germany. . . . . . . . 134,563 November 2021 Two (5yr.) Manufacturing, Warehouse and Offices
Porta Westfalica, Germany. . . . . . . . 8,930 Month to Month One (1 yr.) Warehouse
Porta Westfalica, Germany. . . . . . . . 13,455 Month to Month None Warehouse and Offices
Sandes, Norway . . . . . . . . . . . . . . . . 807 July 2016 One (6 mos.) Offices
Spanga, Sweden . . . . . . . . . . . . . . . . 16,146 Own — Warehouse and Offices
Thiene, Italy . . . . . . . . . . . . . . . . . . . 21,528 Own — Warehouse and Offices
Trondheim, Norway . . . . . . . . . . . . . 5,027 December 2018 One (6 mos.) Services and Offices
Warwick, United Kingdom. . . . . . . . 135,413 May 2017 One (3 yr.) Warehouse and Offices
Wien, Austria . . . . . . . . . . . . . . . . . . 215 Month to Month None Warehouse
Witterswil, Switzerland . . . . . . . . . . 40,343 March 2018 One (1 yr.) Manufacturing, Warehouse and Offices
Witterswil, Switzerland . . . . . . . . . . 2,241 Month to Month None Warehouse
Witterswil, Switzerland . . . . . . . . . . 2,241 Month to Month None Warehouse
Witterswil, Switzerland . . . . . . . . . . 4,306 Month to Month One (3 mos.) Warehouse
Item 3. Legal Proceedings.
In the ordinary course of its business, the company is a defendant in a number of lawsuits, primarily product liability actions
in which various plaintiffs seek damages for injuries allegedly caused by defective products. All of the product liability lawsuits
that the company faces in the United States have been referred to the company's captive insurance company and/or excess insurance
carriers while all non-U.S. lawsuits have been referred to the company's commercial insurance carriers. All such lawsuits are
generally contested vigorously. The coverage territory of the company's insurance is worldwide with the exception of those countries
with respect to which, at the time the product is sold for use or at the time a claim is made, the U.S. government has suspended
or prohibited diplomatic or trade relations. Management does not believe that the outcome of any of these actions will have a
material adverse effect upon the company's business or financial condition.
In December 2012, the company reached agreement with the FDA on the terms of the consent decree of injunction with
respect to the company's Corporate facility and its Taylor Street wheelchair manufacturing facility in Elyria, Ohio. A complaint
and consent decree were filed in the U.S. District Court for the Northern District of Ohio, and on December 21, 2012, the Court
approved the consent decree and it became effective. The consent decree limits the company's manufacture and distribution of
power and manual wheelchairs, wheelchair components and wheelchair sub-assemblies at or from its Taylor Street manufacturing
facility. The decree also initially limited design activities related to wheelchairs and power beds that take place at the impacted
Elyria, Ohio facilities. The company is entitled to continue to produce from the Taylor Street manufacturing facility certain
medically necessary wheelchairs provided that documentation and record-keeping requirements are followed, as well as ongoing
replacement, service and repair of products already in use, under terms delineated in the consent decree. Under the terms of the
consent decree, in order to resume full operations at the impacted facilities, the company must successfully complete a third-party
expert certification audit at the impacted Elyria facilities, which is comprised of three distinct reports that must be submitted to,
and accepted by, the FDA. During 2013, the company completed the first two of the third-party expert certification audits, and
the FDA found the results of both to be acceptable. In these reports, the third-party expert certified that the company's equipment
and process validation procedures and its design control systems are compliant with the FDA's QSR. As a result of the FDA's
acceptance of the first certification report on May 13, 2013, the Taylor Street facility was able to resume supplying parts and
components for the further manufacturing of medical devices at other company facilities. The company's receipt of the FDA's
acceptance of the second certification report on July 15, 2013, resulted in the company being able to resume design activities at
the impacted facilities related to power wheelchairs and power beds. In February 2016, the independent expert auditor issued its
certification report for the third phase of the consent decree indicating substantial compliance with the FDA's QSR, and the report
has been submitted to the FDA.